DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI
Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a...
By Mark Bergen, Rebecca Torrence · Bloomberg
Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a reality.